AVTE – aerovate therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $41.00 price target on the stock.
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights [Yahoo! Finance]
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "outperform" rating re-affirmed by analysts at Wedbush.
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $35.00 price target on the stock.
Form 10-Q Aerovate Therapeutics, For: Mar 31
Form 8-K Aerovate Therapeutics, For: May 13
Form 4 Aerovate Therapeutics, For: May 02 Filed by: Verwijs Marinus
Form 4 Aerovate Therapeutics, For: May 01 Filed by: NOYES TIMOTHY P
Form 144 Aerovate Therapeutics, Filed by: Verwijs Marinus
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.